Equity Research Fats & Oils

Should You Buy Bunge Limited Stock in 2026?

By CirclFi Research Team · · 13/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Bunge Limited (BG) carries a solid Quality of Company rating of 7.0/10. Trading at $120.49, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 2 of 13 CirclFi valuation models project upside for Bunge Limited (BG) at $120.49 — the model consensus leans bearish, with a Quality Score of 7.0/10 and Value-Trap risk of 12/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 11 of 13 models suggest overvaluation — majority bearish
  • Quality Score: 7.0/10 — Strong — above-average quality
  • Value Trap Risk: 12/100 — Minimal — healthy fundamentals
  • Fair Value Range: $4.05 – $132.99 (3187% spread)

Bullish Models

2 / 13

Bearish Models

11 / 13

Quality Score

7.0 /10

Strong — above-average quality

Value Trap Risk

12 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

13 /13
Active Models

Avg. confidence: 40%

Investment Thesis

The Bull Case

Target: $132.99 (+10.4% upside)

  • According to the CirclFi Quality of Company (QOC) framework, Bunge Limited's quality score of 7.0/10 demonstrates the operational excellence that historically correlates with long-term shareholder value creation.
  • Industry tailwind: commodity price environment could provide meaningful support for Bunge Limited's revenue and margin trajectory in the Fats & Oils space.

The Bear Case

Target: $4.05 (-96.6%)

  • According to the CirclFi Deep Alpha Valuation Engine, the RCMH-DCF model sees the stock as overvalued with a fair value of $4.05 (-96.6%), suggesting that the market price embeds overly optimistic growth assumptions.
  • According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +107.0% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.
  • Industry headwind: stranded asset risk represents a meaningful risk for Bunge Limited and its Fats & Oils peers.

Peer Benchmarking

DAR Darling Ingredients
7.7
COOT Australian Oilseeds
4.6

Valuation Divergence

Spread

3187%

Fair Value Range

$4.05 – $132.99

A 3187% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Markov DDM

$132.99 (+10.4%)

Most Bearish

RCMH-DCF

$4.05 (-96.6%)

Key Risk Factors

Model Disagreement

3187% spread signals high variance in projections.

Bearish Consensus

11/13 models suggest overvaluation.

Macro/Sector Risk

Fats & Oils headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View BG Data Page →

The Bottom Line

Our valuation engine sends a clear cautionary signal on Bunge Limited at $120.49. 11/13 models flag overvaluation, composite fair value sits at $59.65 (-50.5%), and the risk-reward profile appears unfavorable. Quality at 7.0/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. Bunge Limited's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

Frequently Asked Questions

Should I buy BG stock right now?

Based on CirclFi's multi-model analysis, 2 of 13 models see upside for BG at $120.49. The models are divided, which means the investment case depends heavily on your assumptions about Bunge Limited's future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Bunge Limited?

Key risks include: wide model disagreement (3187% spread), signaling high uncertainty; general market and sector-specific risks affecting Fats & Oils companies. Always diversify and consult a financial advisor.

How does BG compare to its competitors?

Among Fats & Oils peers, BG holds a Quality Score of 7.0/10. Comparable companies include DAR (QOC 7.7), COOT (QOC 4.6). The relative ranking helps investors identify whether BG offers better fundamental quality than alternatives in the same sector.

Is BG a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BG's Quality Score of 7.0/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy BG at?

CirclFi does not provide target buy prices or price alerts. However, our 13 active models produce fair value estimates ranging from $4.05 to $132.99. At $120.49, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for BG.

View BG Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →